Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Outlook for the Outpatient Oncology Infusion Market Heading Into 2029?

The market size for outpatient oncology infusion has seen robust growth in past few years, with a projected rise from $12.99 billion in 2024 to $14.02 billion in 2025, representing a compound annual growth rate (CAGR) of 7.9%. The surge in the historical period can be attributed to factors such as increased occurrence of cancer, growth in outpatient centers, patients favoring more homely environments, improved insurance coverage, a shift from inpatient to outpatient care, and higher survival rates.

In the coming years, the outpatient oncology infusion market’s size is predicted to experience considerable growth. The market is anticipated to reach a value of $18.81 billion in 2029, showing a compound annual growth rate (CAGR) of 7.6%. The surge in growth during the projection period is credited to factors such as the increasing elderly population, rising demand for personalized medicine, the growing use of biosimilars, focus on containing costs, value-based reimbursement models, and staff shortages. Key trends in the projected period encompass advancements in infusion devices, the adoption of telehealth services, technology-supported remote patient monitoring, advancements in personalized treatment, and progress in targeted therapies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25861&type=smp

Which Factors Are Pushing The Outpatient Oncology Infusion Market Forward?

The surge in cancer cases is predicted to drive the expansion of the outpatient oncology infusion market. Cancer, being a cluster of diseases characterized by uncontrolled proliferation of abnormal cells that can invade other tissues and spread throughout the body, has seen a rise in incidence primarily due to the aging global population, given that the risk of cancer increases substantially with age. Outpatient oncology infusion allows for the administration of cancer treatments like chemotherapy, immunotherapy, or targeted therapy in a clinic, eliminating the need for hospital admission and enabling patients to continue their day-to-day activities. For example, Macmillan Cancer Support, a UK charitable organization offering practical, emotional and financial assistance to those affected by cancer, predicted in April 2024 that the number of people living with cancer in the UK, which sits over 3 million currently, will rise to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Therefore, the escalating incidence of cancer is fuelling the expansion of the outpatient oncology infusion market.

Which Segment Held The Largest Share In The Outpatient Oncology Infusion Market In 2025?

The outpatient oncology infusion market covered in this report is segmented –

1) By Product: Infusion Pumps, Intravenous Sets, Intravenous Cannulas, Needleless Connectors

2) By Therapy: Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy

3) By Application: Lung Cancer, Liver Cancer, Breast Cancer, Prostate Cancer, Other Cancers

4) By End-User: Hospitals, Outpatient Clinics, Home Care Settings

Subsegments:

1) By Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Elastomeric Infusion Pumps, Ambulatory Infusion Pumps, Smart Infusion Pumps

2) By Intravenous Sets: Vented IV Sets, Non-Vented IV Sets, Gravity IV Sets, Pump-Compatible IV Sets, Filtered IV Sets

3) By Intravenous Cannulas: Peripheral IV Cannulas, Central IV Cannulas, Winged IV Cannulas (Butterfly), Closed IV Cannulas, Safety IV Cannulas

4) By Needleless Connectors: Positive Displacement Connectors, Negative Displacement Connectors, Neutral Displacement Connectors, Closed System Transfer Devices (CSTDs), Anti-Reflux Connectors

What Notable Trends Are Shaping The Direction Of The Outpatient Oncology Infusion Market?

Leading firms in the outpatient oncology infusion market are centring their efforts on groundbreaking products like syringe infusion pumps to amplify infusion precision, optimize patient security, and modernize medication distribution via superior software and dose error reduction systems. Commonly known as a syringe driver, a syringe infusion pump is a motor-operated apparatus engineered to meticulously administer fluid flow by mechanically maneuvering the plunger of a syringe. For example, in August 2022, U.S. healthcare firm Baxter International Inc., notable for its expertise in surgical and intravenous infusion strategies, acquired U.S. Food and Drug Administration approval for their Novum IQ Syringe Infusion Pump integrated with the Dose IQ Safety Software. This system employs Baxter’s advanced, internet-based Dose IQ platform, custom-built with a drug library and a dose error diminishing apparatus, devised to assist clinicians and healthcare entities by granting centralized, real-time entry to the most recent medication specifics. Adeptly served for outpatient healthcare scenarios, such as outpatient oncology infusion venues, the system ensures precise, programmable infusions of therapeutic substances across various clinical care environments.

Which Organizations Are Driving Progress In The Outpatient Oncology Infusion Industry?

Major companies operating in the outpatient oncology infusion market are Medtronic plc, Becton Dickinson and Company, Baxter International Inc., Fresenius Kabi AG, Terumo Corporation, Nipro Corporation, Smiths Medical Inc., ICU Medical Inc., B. Braun Melsungen AG, InfuSystem Holdings Inc., BPL Medical Technologies Private Limited, Angiplast Private Limited, Bio-Med Healthcare Products Private Limited, Lars Medicare Private Limited, Micrel Medical Devices S.A., AKAS Infusions Private Limited, Mais India Medical Devices Private Limited, Wellead Medical Co. Ltd., AdvaCare Pharma USA LLC, Polymed Medical Devices Private Limited.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/outpatient-oncology-infusion-global-market-report

Which Region Is Expected To Experience The Highest Growth In The Outpatient Oncology Infusion Industry?

North America was the largest region in the outpatient oncology infusion market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the outpatient oncology infusion market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=25861&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model